Antibody Therapy Eradicates Traces of Multiple Myeloma in Preliminary Trial
By: Wynne Parry | December 06, 2025 | 7 min. read | Share Summary Sylvester Comprehensive Cancer Center researchers…
A plain language summary of the CEPHEUS study: D-VRd for newly diagnosed multiple myeloma patients who are not expected to receive a stem cell transplant
The CEPHEUS study evaluated the effectiveness of adding daratumumab to the standard VRd regimen (bortezomib, lenalidomide, and dexamethasone)…
Tip Sheet: What cancer patients need to know about tumor markers, a new cancer genetics atlas — and educational programs for students and teachers
SEATTLE — Sept. 3, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
Tip Sheet: What cancer patients need to know about tumor markers, a new cancer genetics atlas — and educational programs for students and teachers
SEATTLE — Sept. 3, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
Genomic clues uncover early origins of multiple myeloma
A new study maps out the timeline of DNA damage for multiple myeloma, the second most common blood…